Literature DB >> 8873080

Neurotrophin-4/5 treatment reduces infarct size in rats with middle cerebral artery occlusion.

K M Chan1, D T Lam, K Pong, H R Widmer, F Hefti.   

Abstract

The aim of this study was to determine whether neurotrophin-4/5 (NT-4/5) treatment alters infarction volume following permanent focal cerebral ischemia in the rat. Permanent focal cerebral ischemia was produced in adult male rats by intraluminal occlusion of the right middle cerebral artery. NT-4/5 was administered intraventricularly one day before and immediately following occlusion. Rats were sacrificed at 1, 4 and 7 days after occlusion. NT-4/5 treatment reduced infarction volume by 34% when compared to control rats 1 day after occlusion. Infarction volume was unaltered by treatment 4 to 7 days after occlusion. Middle cerebral artery occlusion led to a significant reduction in levels of mRNAs coding for catalytic and truncated TrkB receptors. This expression was unaffected by NT-4/5 treatment.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8873080     DOI： 10.1007/bf02532298

Source DB:  PubMed          Journal:  Neurochem Res        ISSN： 0364-3190            Impact factor:   3.996


  31 in total

1.  Amelioration of delayed neuronal death in the hippocampus by nerve growth factor.

Authors:  T Shigeno; T Mima; K Takakura; D I Graham; G Kato; Y Hashimoto; S Furukawa
Journal:  J Neurosci       Date:  1991-09       Impact factor: 6.167

2.  Primary structure and biological activity of a novel human neurotrophic factor.

Authors:  A Rosenthal; D V Goeddel; T Nguyen; M Lewis; A Shih; G R Laramee; K Nikolics; J W Winslow
Journal:  Neuron       Date:  1990-05       Impact factor: 17.173

3.  Changes in insulin-like growth factor 1 receptor density after transient cerebral ischemia in the rat. Lack of protection against ischemic brain damage following injection of insulin-like growth factor 1.

Authors:  K Bergstedt; T Wieloch
Journal:  J Cereb Blood Flow Metab       Date:  1993-09       Impact factor: 6.200

4.  Time course, localization and pharmacological modulation of immediate early inducible genes, brain-derived neurotrophic factor and trkB messenger RNAs in the rat brain following photochemical stroke.

Authors:  M C Comelli; D Guidolin; M S Seren; R Zanoni; R Canella; R Rubini; H Manev
Journal:  Neuroscience       Date:  1993-07       Impact factor: 3.590

5.  Failure of basic fibroblast growth factor to prevent postischemic neuronal damage in the rat.

Authors:  H Hara; H Onodera; J Kawagoe; K Kogure
Journal:  Eur J Pharmacol       Date:  1991-12-17       Impact factor: 4.432

6.  Increased production of the TrkB protein tyrosine kinase receptor after brain insults.

Authors:  J P Merlio; P Ernfors; Z Kokaia; D S Middlemas; J Bengzon; M Kokaia; M L Smith; B K Siesjö; T Hunter; O Lindvall
Journal:  Neuron       Date:  1993-02       Impact factor: 17.173

7.  Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal cerebral ischemia in rats.

Authors:  N Koketsu; D J Berlove; M A Moskowitz; N W Kowall; C G Caday; S P Finklestein
Journal:  Ann Neurol       Date:  1994-04       Impact factor: 10.422

8.  Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus.

Authors:  T Beck; D Lindholm; E Castrén; A Wree
Journal:  J Cereb Blood Flow Metab       Date:  1994-07       Impact factor: 6.200

9.  Differential regulation of catalytic and non-catalytic trkB messenger RNAs in the rat hippocampus following seizures induced by systemic administration of kainate.

Authors:  M M Dugich-Djordjevic; F Ohsawa; T Okazaki; N Mori; J R Day; K D Beck; F Hefti
Journal:  Neuroscience       Date:  1995-06       Impact factor: 3.590

10.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914
View more
  5 in total

Review 1.  What can we learn about stroke from retinal ischemia models?

Authors:  Philippe M D'Onofrio; Paulo D Koeberle
Journal:  Acta Pharmacol Sin       Date:  2012-12-03       Impact factor: 6.150

2.  Stereotactic coordinates for intracerebroventricular infusion after permanent focal cerebral ischemia in Wistar rats.

Authors:  A Lourbopoulos; S Chatzigeorgiou; T Mavridis; I Kokkinakis; N Tascos; C Simeonidou
Journal:  Hippokratia       Date:  2012-01       Impact factor: 0.471

3.  Brain-derived neurotrophic factor can act as a pronecrotic factor through transcriptional and translational activation of NADPH oxidase.

Authors:  Sun H Kim; Seok J Won; Seonghyang Sohn; Hyuk J Kwon; Jee Y Lee; Jong H Park; Byoung J Gwag
Journal:  J Cell Biol       Date:  2002-12-02       Impact factor: 10.539

4.  Cerebrospinal fluid nerve growth factor levels in patients with Alzheimer's disease.

Authors:  Farhad Mashayekhi; Zivar Salehin
Journal:  Ann Saudi Med       Date:  2006 Jul-Aug       Impact factor: 1.526

5.  Increased expression of neurotrophin 4 following focal cerebral ischemia in adult rat brain with treadmill exercise.

Authors:  Jin-Young Chung; Min-Wook Kim; Moon-Suk Bang; Manho Kim
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.